Macular Degeneration Clinical Trials

Find clinical trials for macular degeneration. Search for macular degeneration clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 123

OCS 01Pivotal Study of OCS-01 Eye Drops in Subjects with Diabetic Macular Edema (DIAMOND-2)

Recruiting

PHASE3

Sponsor:

Oculis

Location:

Palo Alto CA

Code:

NCT06172257

Conditions

Diabetic Macular Edema

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Dexamethasone ophthalmic suspension (OCS-01)

Vehicle

Observational StudyA Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Recruiting

Sponsor:

Hoffmann-La Roche

Location:

Quebec, Phoenix AZ, Beverly Hills CA, Pasadena CAshow 25 more

Code:

NCT05476926

Conditions

Neovascular Age-related Macular Degeneration

Diabetic Macular Edema

Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Central Retinal Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Faricimab

Port Delivery System with Ranibizumab

LucentisSerial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

Recruiting

PHASE3

Sponsor:

The New York Eye & Ear Infirmary

Location:

New York NY

Code:

NCT01255774

Conditions

Age Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 51 - 70+

Healthy Volunteers: Not accepted

Interventions

ranibizumab

OCU410STStudy to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Recruiting

PHASE1

PHASE2

Sponsor:

Ocugen

Location:

Phoenix AZ, Miami FL, Jackson MS, Durham NCshow 2 more

Code:

NCT05956626

Conditions

Stargardt Disease

Eligibility Criteria

Sex: All

Age: 6 - 65

Healthy Volunteers: Not accepted

Interventions

OCU410ST

ALK-001Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Recruiting

PHASE2

Sponsor:

Alkeus Pharmaceuticals, Inc.

Location:

Los Angeles CA, Gainesville FL, Miami FL, Baltimore MDshow 4 more

Code:

NCT02402660

Conditions

Stargardt Disease

Stargardt Macular Degeneration

Stargardt Macular Dystrophy

Autosomal Recessive Stargardt Disease 1 (ABCA4-related)

Eligibility Criteria

Sex: All

Age: 8 - 70

Healthy Volunteers: Not accepted

Interventions

ALK-001

Placebo

InfliximabIntravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Recruiting

PHASE1

Sponsor:

Retina Research Foundation

Location:

SLingerlands NY

Code:

NCT00695682

Conditions

Diabetic Retinopathy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

intravitreal injection of infliximab

Observational StudyDark Adaptation in Participants With Age-Related Macular Degeneration

Recruiting

Sponsor:

National Eye Institute (NEI)

Location:

Bethesda MD

Code:

NCT03225131

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

NG101NG101 AAV Gene Therapy in Subjects with Wet Age-Related Macular Degeneration

Recruiting

PHASE1

PHASE2

Sponsor:

Neuracle Genetics, Inc

Location:

Cincinnati OH, Vancouver, Toronto

Code:

NCT05984927

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

NG101 AAV gene therapy

Avacincaptad PegolA Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Recruiting

Sponsor:

Astellas Pharma Global Development, Inc.

Location:

Phoenix AZ, Scottsdale AZ, Redlands CA, Altamonte Springs FLshow 6 more

Code:

NCT06779773

Conditions

Geographic Atrophy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Avacincaptad pegol (ACP)

ElamipretideReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

PHASE3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Phoenix AZ, Sun City AZ, Huntington Beach CA, Poway CAshow 30 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo